Inclusion Criteria:

• Age 16-55 years old.
• Medial, lateral, vertical longitutdinal, oblique, or radial meniscal tear.
• Complex tears may be included (investigator discetion) if the patient has one of the tear patterns listed in incluse as the predominant finding.
• No other concomitant procedures unless (one of the following):
  • Chondroplasty;
  • Synovectomy;
  • Loose body removal;
  • “Contralateral” menisectomy (i.e., medial meniscus repair with a lateral menisectomy or lateral meniscus repair with a medial menisectomy) would be permitted for inclusion;
  • Any other procedure that does not include drilling, requires prior approval of the study sponsor for each procedure.

Exclusion Criteria:

• Patients requiring cartilage restorative or repair procedures (i.e., OCD fixation, micro-fracture repair, or others).
• Patients with meniscus root tears.
• Patients undergoing repair for horizontal cleavage tears.
• Kellgren-Lawrence scale > 2.
• Patients undergoing lateral release.
• Ipsilateral chondral lesion with Outerbridge classification of 3-4.
• Use of prednisone or other steroids, any immunosuppressant, or chemotherapy 1-week before surgery or expected use within six weeks after surgery.
• Cortisone use within the six weeks prior to surgery.
• Utilizing worker’s compensation at the time of screening.
• Any previous ligament surgery on the index limb. Any previous meniscal surgery on the index meniscus.
• Concomitant ligamentous insufficiency.
• Inflammatory rheumatic disease or other rheumatic disease.
• Immune compromised patients (hepatitis, HIV, etc.).
• Any nicotine based products within the three months prior to surgery (including cigarettes, cigars, vaping, nicotaine patch, etc.).
• History of distal femur, proximal tibia, or patellar fracture that was treated operatively.
• Non English-speaking patients.